The New England journal of medicine
The Role of Interferon-? in Autoimmune Polyendocrine Syndrome Type 1.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply.
STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.
Tolerance in the Age of Immunotherapy.
Teprotumumab for Active Thyroid Eye Disease.
Autoimmune Polyendocrine Syndromes.
HDL cholesterol efflux capacity and cardiovascular events.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Vitamin D-binding protein and vitamin D in blacks and whites.
